Gentel Biosciences

Gentel, Van Andel Institute Claim New Tech For Early Cancer DiagnosisMadison, Wis.-based Gentel Biosciences, a leader in proteomics tools, and the Grand Rapids-based Van Andel Research Institute, a biomedical research institute, jointly announce today the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen